NCT06533241

Brief Summary

This study will be conducted on pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

July 30, 2024

Last Update Submit

August 2, 2024

Conditions

Renal Diseases

Outcome Measures

Primary Outcomes (1)

  • the indications of renal biopsy

    investigate the indications of renal biopsy in pediatric patients at Tanta University Hospital for 10 years from 2012 to 2022

    3 months

Secondary Outcomes (1)

  • light , electron microscope and immunofluorescence results of renal biopsy

    3 months

Study Arms (1)

pediatric patients less than 18 years' old who underwent renal biopsy

pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.

Procedure: renal biopsy

Interventions

renal biopsyPROCEDURE

percutaneous renal biopsy procedure

pediatric patients less than 18 years' old who underwent renal biopsy

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All pediatric patients less than 18 years' old who underwent renal biopsy.

You may qualify if:

  • All pediatric patients less than 18 years' old who underwent renal biopsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sara Mabrouk Mohamed Elghoul

Tanta, Tanta, Qism 1, 31511, Egypt

Location

MeSH Terms

Conditions

Kidney Diseases

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Sara Mabrouk Mohamed Elghoul, MD

    Tanta University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Lecturer of Pediatric Nephrology

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 1, 2024

Study Start

November 28, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

August 6, 2024

Record last verified: 2024-08

Locations

EG(1)